This study is in progress, not accepting new patients
A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)
Summary
- Eligibility
- for people ages 7 years and up (full criteria)
- Location
- at UCLA UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- BioMarin Pharmaceutical
- ID
- NCT02724228
- Phase
- Phase 2 Achondroplasia Research Study
- Study Type
- Interventional
- Participants
- About 30 people participating
- Last Updated